Zhejiang Medicine Co. Ltd.
www.china-zmc.com/index_en.asp
Latest From Zhejiang Medicine Co. Ltd.
Asia Deal Watch: Ambrx, NovoCodex Partner On Second ADC Candidate, For CD70-Positive Cancers
Deal follows 2013 pact between Ambrx and NovoCodex parent Zhejiang Medicine for HER2-positive-directed ADC. Astellas teams with Pandion on pancreatic cancer and Takeda with MD Anderson on CAR NK therapies.
WuXi Biologics To Be ‘World’s No.1’ Biologics Maker
WuXi Biologics is aiming high to become the world’s biggest biologics manufacturer within five years after seeing strong confidence from capital markets in its growth potential and a boost from its new biologics manufacturing facility. The Chinese company plans on more investment in early 2018 to prepare for an expected biologics surge in China, its chief executive tells Scrip.
Cancer’s Next-Gen Smart Bomb: Who Will Be First To Weaponize?
With 70 clinical trials now underway on a “next generation” of more precisely targeted antibody drug conjugates, In Vivo profiles Ambrx and Sutro Biopharma, two smaller biotechs with promising technologies and powerful partners that augment their strong science with disease awareness, deep commercial networks and global geographic reach.
Deal Watch: Seattle Genetics' Controversial Collaboration With Immunomedics Topples
A licensing deal between the two cancer-focused biotechs falls apart amidst investor unrest at Immunomedics. Novartis opts to license Conatus' Phase II NASH candidate and picks up a CAR-T candidate from Celyad, while Shire adds to its dry eye franchise in deal with Parion.
Company Information
- Industry
-
Pharmaceuticals
- Nutraceuticals
- Therapeutic Areas
- Infectious & Viral Diseases
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
Asia
-
China
-
China
-
Asia
- Parent & Subsidiaries
- Zhejiang Medicine Co. Ltd.
- Senior Management
-
Chun Feng Li, CFO
Xiao Yue Jiang, Acting General Mgr. - Contact Info
-
Zhejiang Medicine Co. Ltd.
Phone: 571 8721 3883
No. 268 Dengyun Rd.
Gongshu Dist.
Hangzhou, 310011
China
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice